Evidence-based guidelines in Polycystic Ovary Syndrome (PCOS) update and expansion project
One of the major projects of the Centre for Research Excellence in PCOS is to update and expand the Evidence-based guideline for the assessment and management of PCOS, approved by the NHMRC in 2011. The update to the guideline is an international collaboration involving many internationally recognised researchers and multidisciplinary clinicians as well as consumers with PCOS and is proposed to be the primary, international evidence-based guideline in PCOS. Many national and international societies/ organisations have agreed to collaborate/ partner with us and to contribute funding.
The project is governed by a Project Board, with guidance from an International Advisory Committee and directed by Professor Helena Teede. The guideline will be developed in compliance with the Australian National Health and Medical Research Council rigorous practices for developing evidence-based guidelines and will be submitted for NHMRC Council approval in approximately June 2018.
Progress to date:
- Extensive national and international stakeholder consultation has occurred to identify topic priorities for inclusion in the guideline via a Delphi survey. To date, more than 600 survey responses have been received.
- Five international guideline development groups have been formed to develop evidence-based or consensus (where evidence is lacking) clinical guidance in the following theme areas:
- Screening, diagnostic assessment, risk assessment, life-stage and adolescents
- Screening, diagnostic assessment and management of emotional wellbeing
- Lifestyle management and models of care
- Medical treatment (ie metformin/OCP etc. for features of PCOS)
- Screening, diagnostic assessment and management of infertility
- Guideline development groups have determined topic priorities and clinical questions to be addressed in the guideline.
- Evidence synthesis is well underway for all of the prioritised clinical questions to be answered in the guideline
- International guideline development group meetings have been arranged in July 2017 in Geneva and November 2017 in San Antonio to consider evidence reviews and develop guideline content.
- An extensive international campaign has been undertaken to invite collaboration in the project with national/ international peak societies/ organisations in PCOS. Uptake of the invitation has been phenomenal. We now have 15 international and 6 national societies which have agreed to partner/ collaborate in the project.
- A public consultation process will occur in late 2017/ early 2018. We will invite all stakeholder groups (societies/organisations), both nationally and internationally to comment on draft guideline content prior to finalising.
For further information about the CRE-PCOS please refer towww.pcos-cre.edu.au